Close Menu

New Releases: Dec 15, 2010

Premium

Ipsogen this week launched of a new line of assays that enable the standardization of quantitative analysis of BCR-ABL Mbcr by calibrating the results on the International Scale.

Ipsogen said that its BCR-ABL Mbcr IS-MMR DX and BCR-ABL Mbcr IS-MMR kits have CE-marking and are already available in Europe and other non-US markets. Research-use-only kits are planned for launch in North America next year.

Standardization of the analysis of BCR-ABL transcripts is increasingly viewed as medically necessary when administering drugs like Gleevec.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

A new study finds that three dimensional facial scans may be able to aid in diagnosing rare genetic diseases.

The Lancet and the New England Journal of Medicine have retracted two COVID-19 papers due to concerns about the data used in their analyses.

Lawmakers plan to introduce a bill that aims to prevent the theft of US-funded research, according to the Wall Street Journal.

In Science this week: analysis of ancient Caribbean islanders' genomes suggests at least three waves of migration into the region,  DNA barcoding of microbial spores, and more.

Jul
15
Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.